Artificial Intelligence in Diabetes Care: Applications, Challenges, and Opportunities Ahead.

IF 3.7 3区医学 Q2 ENDOCRINOLOGY & METABOLISM

Endocrine Practice Pub Date : 2025-07-17 DOI:10.1016/j.eprac.2025.07.008

Rohit Parab, Jenna M Feeley, Maria Valero, Laya Chadalawada, Gian-Gabriel P Garcia, Sudeshna Sil Kar, Anant Madabhushi, Marc D Breton, Jing Li, Hui Shao, Francisco J Pasquel

{"title":"Artificial Intelligence in Diabetes Care: Applications, Challenges, and Opportunities Ahead.","authors":"Rohit Parab, Jenna M Feeley, Maria Valero, Laya Chadalawada, Gian-Gabriel P Garcia, Sudeshna Sil Kar, Anant Madabhushi, Marc D Breton, Jing Li, Hui Shao, Francisco J Pasquel","doi":"10.1016/j.eprac.2025.07.008","DOIUrl":null,"url":null,"abstract":"<p><p>Artificial intelligence (AI) is rapidly transforming clinical medicine, and its potential impact on diabetes care is particularly noteworthy. In recent years, both traditional machine learning approaches and deep learning algorithms have been applied to improve screening for complications of diabetes such as retinopathy, macular edema, and neuropathy, predict disease progression risk, and enhance clinical decision support systems for diagnosis, prognosis, and treatment optimization. AI-driven solutions are also emerging to identify noninvasive biomarkers for detecting diabetes and prediabetes, analyze the macronutrient content of meals using image-based deep learning methods, integrate novel risk prediction tools within electronic health records, and optimize automated insulin delivery (AID) systems. These advancements hold promise for streamlining patient care, personalizing treatment plans, and ultimately improving clinical outcomes. In this narrative review, we examine the latest AI applications in diabetes care, exploring their capabilities, limitations, and the future directions necessary to realize their full potential to improve the care of people living with diabetes.</p>","PeriodicalId":11682,"journal":{"name":"Endocrine Practice","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.eprac.2025.07.008","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Artificial intelligence (AI) is rapidly transforming clinical medicine, and its potential impact on diabetes care is particularly noteworthy. In recent years, both traditional machine learning approaches and deep learning algorithms have been applied to improve screening for complications of diabetes such as retinopathy, macular edema, and neuropathy, predict disease progression risk, and enhance clinical decision support systems for diagnosis, prognosis, and treatment optimization. AI-driven solutions are also emerging to identify noninvasive biomarkers for detecting diabetes and prediabetes, analyze the macronutrient content of meals using image-based deep learning methods, integrate novel risk prediction tools within electronic health records, and optimize automated insulin delivery (AID) systems. These advancements hold promise for streamlining patient care, personalizing treatment plans, and ultimately improving clinical outcomes. In this narrative review, we examine the latest AI applications in diabetes care, exploring their capabilities, limitations, and the future directions necessary to realize their full potential to improve the care of people living with diabetes.

查看原文本刊更多论文

人工智能在糖尿病护理中的应用、挑战和机遇。

人工智能（AI）正在迅速改变临床医学，其对糖尿病护理的潜在影响尤其值得注意。近年来，传统的机器学习方法和深度学习算法都被应用于改善糖尿病并发症（如视网膜病变、黄斑水肿和神经病变）的筛查，预测疾病进展风险，增强临床决策支持系统的诊断、预后和治疗优化。人工智能驱动的解决方案也正在出现，以识别用于检测糖尿病和前驱糖尿病的无创生物标志物，使用基于图像的深度学习方法分析膳食中的宏量营养素含量，在电子健康记录中集成新的风险预测工具，并优化自动化胰岛素输送（AID）系统。这些进步有望简化患者护理，个性化治疗计划，并最终改善临床结果。在这篇叙述性综述中，我们研究了人工智能在糖尿病护理中的最新应用，探讨了它们的能力、局限性，以及充分发挥其潜力改善糖尿病患者护理所必需的未来方向。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Endocrine Practice ENDOCRINOLOGY & METABOLISM-

CiteScore

7.60

自引率

2.40%

发文量

546

审稿时长

41 days

期刊介绍： Endocrine Practice (ISSN: 1530-891X), a peer-reviewed journal published twelve times a year, is the official journal of the American Association of Clinical Endocrinologists (AACE). The primary mission of Endocrine Practice is to enhance the health care of patients with endocrine diseases through continuing education of practicing endocrinologists.